Pricing Log in Create free account

Aligos Therapeutics, Inc. (ALGS) vs LianBio Sponsored ADR (LIANY)

Aligos Therapeutics, Inc. and LianBio Sponsored ADR are both Biotechnology companies. Aligos Therapeutics, Inc. and LianBio Sponsored ADR are of similar size ($34.2M and $33.7M). Aligos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. LianBio Sponsored ADR has the higher net margin (0.00% vs −241.0%) and the higher return on invested capital (−450.5% vs −3,379.3%). Across the 13 metrics below, LianBio Sponsored ADR leads on 10 and Aligos Therapeutics, Inc. on 3.

Valuation

Metric ALGS LIANY Biotechnology median
P/E n/m 0.02 8.50
P/S 1.61 n/m 9.71
P/B 1.59 0.01 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA n/m 5.72 0.64
EV/Sales 0.65 n/m 9.21
Earnings yield (150.21%) 5,773.40% (33.15%)
Free cash flow yield (186.46%) 4,795.89% (25.50%)

Profitability

Metric ALGS LIANY Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (250.63%) 0.00% 0.00%
Net margin (241.01%) 0.00% 0.00%
Free cash flow margin (299.90%) 0.00% 0.00%
Return on equity (113.59%) 70.96% (56.36%)
Return on assets (75.57%) 66.19% (48.04%)
Return on invested capital (3,379.28%) (450.47%) 0.00%

Growth

Metric ALGS LIANY Biotechnology median
Revenue growth (TTM) 893.01% — 6.02%
EPS growth (last fiscal year) 88.30% 75.44% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALGS LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.19 17.03 4.72
Net debt to EBITDA 0.87 7.41 0.96

Dividend

Metric ALGS LIANY Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric ALGS LIANY Biotechnology median
Market cap 33.66m 34.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack